SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-026253
Filing Date
2021-02-22
Accepted
2021-02-22 17:16:37
Documents
4
Period of Report
2021-02-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216851d2_8k.htm 8-K 22409
2 EXHIBIT 1.1 tm216851d2_ex1-1.htm EX-1.1 297499
3 EXHIBIT 5.1 tm216851d2_ex5-1.htm EX-5.1 11693
4 GRAPHIC tm216851d2_ex5-1img001.jpg GRAPHIC 4794
  Complete submission text file 0001104659-21-026253.txt   339465
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 21661427
SIC: 2834 Pharmaceutical Preparations